Already a member? Sign in
Raltegravir is an integrase transfer inhibitor antiretroviral agent used in the treatment of HIV-1 infection in combination with other antiretroviral agents.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| HIV (Human Immunodeficiency Virus) | 120 | 25 |
|
|
|
||
| Support immune health | 5 | 2 |
|
|
|||
| Increase effect of another treatment | 2 | 2 |
|
|
|||
| Other | 1 | 1 |
|
||||
| Participate in clinical trial | 1 | 0 | |||||
| AIDS (Acquired Immune Deficiency Syndrome) | 1 | 0 |
See all 139 patients currently taking raltegravir
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with raltegravir
| Headaches | 3 | |
|---|---|---|
| Nausea | 1 | |
| Dizziness | 1 | |
| Diarrhea | 1 | |
| Chills | 1 | |
| Nausea sometimes | 1 | |
| See all 8 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking raltegravir. See all 13 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 5 | ||
| Course of treatment ended | 3 | ||
| Other | 2 | ||
| Side effects too severe | 1 | ||
| Change in health plan coverage | 1 |
Adherence
Taking treatment as prescribed
Adherence of raltegravir
Always |
26 | 87% |
|
|---|---|---|---|
Usually |
4 | 13% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of raltegravir
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
11 | 37% |
|
Not at all |
19 | 63% |
|
Cost
Paid out of pocket
Cost of raltegravir
$200+ |
1 | 6% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
3 | 17% |
|
$25-49 |
4 | 22% |
|
< $25 |
10 | 56% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 28, 2012.